hypothes
host
antivir
gene
induc
type
interferon
might
affect
natur
cours
sever
acut
respiratori
syndrom
sar
analyz
singl
nucleotid
polymorph
snp
oligoadenyl
synthetas
myxoviru
resistancea
mxa
doublestrand
rnadepend
protein
kinas
vietnames
sar
patient
control
gallel
nonsynonym
ag
snp
exon
gene
show
associ
sar
p
gallel
exon
one
exon
strong
linkag
disequilibrium
associ
sar
infect
gg
genotyp
gallel
gt
snp
posit
mxa
gene
promot
found
frequent
hypoxem
group
nonhypoxem
group
sar
p
find
suggest
polymorph
two
ifninduc
gene
mxa
might
affect
suscept
diseas
progress
sar
level
sever
acut
respiratori
syndrom
sar
new
infecti
diseas
emerg
toward
end
spread
china
countri
asia
europ
north
america
outbreak
total
case
sar
diagnos
mortal
rate
risk
factor
exacerb
clinic
progress
sar
report
patient
excess
year
age
diabet
mellitu
comorbid
medic
condit
howev
littl
known
host
genet
factor
associ
develop
progress
sar
except
human
leukocyt
antigen
insertiondelet
polymorph
angiotensin
convert
enzym
gene
whose
associ
diseas
research
group
identifi
shown
sar
caus
newli
identifi
sar
coronaviru
sarscov
among
innat
immun
viral
infect
type
interferon
ifnab
induc
viru
infect
gener
play
import
role
first
line
defens
induc
intracellular
antivir
protein
synthetas
myxoviru
resistancea
mxa
doublestrand
rnadepend
protein
kinas
pkr
although
induct
endogen
type
ifn
sarscov
infect
vivo
yet
clarifi
recent
studi
shown
administr
exogen
type
ifn
could
inhibit
sarscov
replic
vivo
vitro
investig
role
ifn
system
sarscov
infect
import
understand
mechan
viral
pathogenesi
also
adopt
effect
therapeut
strategi
sar
host
genet
factor
influenc
antivir
effect
ifn
well
studi
field
viral
hepat
type
ifn
wide
use
antivir
agent
mainli
treat
hepat
c
viru
hcv
infect
host
genet
factor
affect
outcom
ifn
treatment
chronic
hepat
c
investig
singl
nucleotid
polymorph
snp
promot
region
ifninduc
mxa
gene
associ
respons
ifn
treatment
japanes
caucasian
popul
snp
mxa
gene
snp
gene
pkr
gene
also
shown
associ
selflimit
infect
hcv
knapp
et
al
report
indic
snp
ifninduc
gene
associ
result
ifn
treatment
also
natur
cours
hcv
infect
highli
suspect
host
genet
factor
affect
cours
variou
viral
infect
includ
case
sarscov
infect
present
studi
tri
determin
whether
polymorph
ifninduc
gene
associ
sarscov
infect
develop
progress
sar
carri
investig
vietnames
sar
case
control
individu
histori
contact
sar
patient
control
individu
contact
histori
subject
studi
review
approv
ethic
committe
ministri
health
vietnam
well
intern
medic
center
japan
written
inform
consent
obtain
subject
detail
characterist
subject
describ
beforehand
short
studi
popul
compris
sar
patient
vietnam
staff
member
hospit
control
subject
come
contact
sar
patient
develop
sar
individu
reflect
gener
vietnames
popul
contact
histori
sar
patient
sar
patient
requir
oxygen
therapi
hypoxemia
case
hypoxem
receiv
oxygen
therapi
signific
correl
degre
lung
involv
chest
radiograph
requir
supplementari
oxygen
find
progress
sar
lung
could
reason
determin
statu
supplementari
oxygen
ascertain
previou
studi
peripher
blood
sampl
obtain
subject
genom
dna
subsequ
extract
antisarscov
antibodi
blood
sampl
test
sar
elisa
genelab
diagnost
singapor
genotyp
allel
variant
mxa
pkr
gene
snp
analyz
studi
genotyp
util
pcr
restrict
fragment
length
polymorph
rflp
method
held
gene
consist
exon
howev
accord
current
databas
refseq
gene
compris
six
exon
result
ag
snp
rs
exon
gene
associ
outcom
hcv
infect
previou
report
knapp
et
al
locat
exon
fall
untransl
region
long
transcript
detect
snp
genom
dna
amplifi
amplitaq
gold
dna
polymeras
appli
biosystem
primer
gag
gac
tgg
acc
tgc
acc
atc
aga
aag
tca
agg
ctg
gaa
ttt
pcr
product
bp
digest
mboii
new
england
biolab
h
bp
product
cut
presenc
gallel
cut
fragment
presenc
aallel
subsequ
fragment
separ
bp
unit
agaros
gel
ethidium
bromid
found
nonsynonym
snp
exon
gene
regist
jsnp
databas
ie
rs
ag
snp
exon
genotyp
pcr
primer
atc
agg
aat
gga
cct
caa
gac
cgg
atg
agg
ctc
ttg
agc
ttg
rflp
acii
new
england
biolab
pcr
product
bp
digest
acii
electrophores
agaros
gel
analyz
undigest
bp
band
digest
part
bp
band
gt
snp
posit
promot
region
mxa
gene
analyz
pcrrflp
method
describ
previous
gt
snp
posit
associ
result
ifn
treatment
chronic
hepat
c
result
hcv
infect
tc
snp
posit
promot
region
pkr
gene
associ
result
hcv
infect
genotyp
follow
pcr
carri
primer
pkrpf
gtg
gaa
ccc
ttg
att
cga
gaa
cct
pkrpr
gcg
gct
tcg
gga
gag
ctg
gtt
ctc
use
takara
ex
taq
gc
buffer
takara
cycl
condit
cycl
min
pcr
product
purifi
use
qiaquick
pcr
purif
kit
qiagen
digest
sgrai
new
england
biolab
digest
dna
electrophores
agaros
gel
presenc
tallel
demonstr
bp
fragment
presenc
callel
indic
bp
fragment
statist
analysi
possibl
differ
deriv
distribut
age
gender
two
group
evalu
unpair
test
v
test
respect
diseas
associ
assess
v
test
p
valu
less
consid
signific
test
data
analysi
carri
use
jmp
version
sa
institut
genotyp
distribut
test
polymorph
control
popul
hardyweinberg
equilibrium
calcul
jd
j
r
assess
extent
pairwis
linkag
disequilibrium
polymorph
indic
calcul
use
haplotyp
frequenc
estim
phase
algorithm
phase
version
base
bayesian
method
demograph
inform
shown
tabl
mean
age
differ
sar
case
contact
p
although
femal
appear
frequent
sar
case
contact
malefemal
ratio
statist
differ
two
group
p
sixteen
individu
contact
reveal
antisarscov
antibodi
classifi
individu
infect
group
togeth
sar
patient
age
gender
show
signific
differ
infect
noninfect
group
p
sar
case
classifi
requir
oxygen
therapi
age
gender
differ
subgroup
either
p
analyz
snp
ifninduc
gene
show
associ
hcv
infect
describ
compar
genotyp
allel
frequenc
sar
case
control
contact
histori
sar
patient
tabl
observ
higher
frequenc
gallel
posit
genotyp
ga
gg
nonsynonym
snp
exon
gene
sar
patient
odd
ratio
ci
p
allel
frequenc
gallel
exon
significantli
higher
sar
patient
p
allel
frequenc
gallel
exon
also
found
frequent
sar
patient
control
show
margin
signific
p
genotyp
allel
frequenc
polymorph
compar
among
sarscov
infect
individu
uninfect
individu
tabl
shown
frequenc
gallel
exon
exon
significantli
higher
infect
individu
uninfect
p
p
respect
two
polymorph
gene
strong
linkag
disequilibrium
jd
j
r
genotyp
allel
frequenc
control
contact
histori
sar
patient
also
shown
tabl
control
subject
contact
histori
allel
frequenc
gallel
exon
lower
infect
group
higher
uninfect
group
snp
mxa
gene
pkr
gene
associ
develop
sar
tabl
howev
comparison
mxa
genotyp
hypoxem
sar
patient
requir
oxygen
therapi
nonhypoxem
sar
patient
gg
genotyp
found
frequent
patient
former
categori
odd
ratio
ci
p
also
shown
gallel
frequent
former
group
p
tabl
snp
show
signific
p
valu
two
group
data
shown
studi
show
polymorph
ifninduc
gene
might
affect
suscept
sarscov
infect
develop
sar
presenc
doublestrand
rna
dsrna
catalyz
oligom
adenosin
order
permit
bind
activ
latent
ribonucleas
rnase
l
cleav
cellular
viral
rna
gene
two
major
transcript
gener
altern
splice
last
two
exon
short
transcript
exon
translat
isoform
long
transcript
exon
translat
isoform
anoth
transcript
gener
use
differ
splice
acceptor
site
come
exon
translat
protein
protein
uniqu
properti
due
homolog
domain
present
uniqu
carboxyltermin
region
also
distinct
caus
cellular
apoptosi
bind
antiapoptot
protein
famili
therefor
dual
function
repres
synthesi
oligom
adenosin
promot
cellular
apoptosi
knapp
et
al
describ
gg
genotyp
exon
gene
frequent
persist
hcv
infect
selflimit
infect
studi
gallel
frequent
observ
sarscov
infect
individu
uninfect
group
studi
gallel
suscept
viru
infect
ag
polymorph
exon
locat
downstream
stop
codon
transcript
mean
therefor
includ
untransl
region
howev
locat
upstream
stop
codon
ag
snp
result
amino
acid
substitut
protein
locat
near
homolog
domain
amino
acid
posit
interest
aspect
phenomenon
occur
function
import
also
analyz
ag
polymorph
exon
gene
found
strong
linkag
disequilibrium
two
snp
ag
polymorph
exon
caus
amino
acid
substitut
three
isoform
locat
near
dsrna
bind
domain
amino
acid
posit
unabl
point
determin
snp
directli
relat
suscept
sar
sarscov
infect
one
also
consid
unidentifi
polymorph
strong
linkag
disequilibrium
snp
may
serv
basi
function
differ
judg
result
obtain
studi
polymorph
gene
like
involv
sarscov
infect
develop
sar
least
part
bear
mind
fact
might
antivir
potenti
sarscov
sarscov
usual
cultur
vero
cell
line
produc
ifn
lack
ifn
gene
recent
cinatl
et
al
infect
permiss
cell
sarscov
analyz
effect
sarscov
cellular
gene
express
highdens
oligonucleotid
array
found
sarscov
infect
cell
upregul
ifninduc
oasl
mxa
pkr
gene
oasl
member
human
oa
gene
famili
role
inhibitor
sarscov
replic
clarifi
examin
hypothesi
cell
permit
consider
infect
sarscov
induc
regard
gt
polymorph
posit
promot
region
mxa
gene
gg
genotyp
gallel
found
frequent
patient
enhanc
clinic
progress
requir
oxygen
therapi
although
number
case
rather
small
gg
genotyp
found
frequent
nonrespond
ifn
treatment
hepat
c
luciferas
report
assay
reveal
mxa
promot
sequenc
g
haplotyp
lower
promot
activ
haplotyp
recent
arca
et
al
report
gg
genotyp
express
lower
amount
mxa
mrna
gt
tt
genotyp
ifntreat
peripher
report
sarscov
replic
affect
vero
cell
stabli
express
mxa
conclud
antivir
effect
ifn
sarscov
mediat
mxa
studi
snp
mxa
promot
relat
diseas
suscept
take
observ
togeth
mxa
may
strong
inhibitori
effect
replic
sarscov
lower
mxa
express
may
play
role
worsen
sar
clinic
progress
sar
reemerg
ifn
could
promis
candid
treat
sar
patient
present
studi
snp
associ
sarscov
infect
develop
sar
snp
mxa
associ
progress
sar
could
interest
consid
may
also
relat
respons
sar
patient
ifn
sar
patient
aa
genotyp
ag
snp
exon
may
respond
ifn
treatment
effect
ag
gg
genotyp
cours
studi
age
risk
factor
contribut
worsen
sar
probabl
major
patient
consist
rel
young
medic
staff
member
conclus
show
polymorph
gene
associ
sarscov
infect
develop
sar
polymorph
mxa
gene
also
associ
hypoxem
statu
sar
case
vietnam
find
may
lead
understand
ifninduc
antivir
respons
sar
infect
